Influence of cortisol on adipose tissue development in the fetal sheep during late gestation.
The present study examined the extent to which the late gestation rise in fetal plasma cortisol influenced adipose tIssue development in the fetus. The effect of cortisol on the abundance of adipose tIssue mitochondrial proteins on both the inner (i.e. uncoupling protein (UCP)1) and outer (i.e. voltage-dependent anion channel (VDAC)) mitochondrial membrane, together with the long and short forms of the prolactin receptor (PRLR) protein and leptin mRNA was determined. Perirenal adipose tIssue was sampled from ovine fetuses to which (i) cortisol (2-3 mg/day for 5 days) or saline was infused up to 127-130 days of gestation, and (ii) adrenalectomised and intact controls at between 142 and 145 days of gestation (term=148 days). UCP1 protein abundance was significantly lower in adrenalectomised fetuses compared with age-matched controls, and UCP1 was increased by cortisol infusion and with gestational age. Adrenalectomy reduced the concentration of the long form of PRLR, although this effect was only significant for the highest molecular weight isoform. In contrast, neither the short form of PRLR, VDAC protein abundance or leptin mRNA expression was significantly affected by gestational age or cortisol status. Fetal plasma triiodothyronine concentrations were increased by cortisol and with gestational age, an affect abolished by adrenalectomy. When all treatment groups were combined, both plasma cortisol and triiodothyronine concentrations were positively correlated with UCP1 protein abundance. In conclusion, an intact adrenal is necessary for the late gestation rise in UCP1 protein abundance but cortisol does not appear to have a major stimulatory role in promoting leptin expression in fetal adipose tIssue. It remains to be established whether effects on UCP1 protein are directly regulated by cortisol alone or mediated by other anabolic fetal hormones such as triiodothyronine.
Mostyn
A
A
Academic Division of Child Health, School of Human Development, Queen's Medical Centre, University Hospital, Nottingham NG7 2UH, UK.
Pearce
S
S
Budge
H
H
Elmes
M
M
Forhead
A J
AJ
Fowden
A L
AL
Stephenson
T
T
Symonds
M E
ME
D002001:Adipose Tissue, Brown / Q000187:drug effects / Q000196:embryology*; D000315:Adrenalectomy; D000818:Animals; D002352:Carrier Proteins / Q000032:analysis / Q000378:metabolism*; D002462:Cell Membrane / Q000737:chemistry; D005260:Female; D005865:Gestational Age; D006854:Hydrocortisone / Q000097:blood / Q000494:pharmacology / Q000502:physiology*; D007473:Ion Channels; D020738:Leptin / Q000032:analysis; D008565:Membrane Proteins / Q000032:analysis / Q000378:metabolism*; D008928:Mitochondria / Q000737:chemistry; D024101:Mitochondrial Proteins; D009924:Organ Culture Techniques; D011247:Pregnancy; D011981:Receptors, Prolactin / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012756:Sheep / Q000196:embryology*; D014284:Triiodothyronine / Q000032:analysis / Q000097:blood; D000071256:Uncoupling Protein 1
D002352:Carrier Proteins; D007473:Ion Channels; D020738:Leptin; D008565:Membrane Proteins; D024101:Mitochondrial Proteins; D011981:Receptors, Prolactin; C000604371:UCP1 protein, human; D000071256:Uncoupling Protein 1; D014284:Triiodothyronine; D006854:Hydrocortisone